Big data for a sustainable future
As discussions on Sustainable Development Goals end this week at the United Nations General Assembly in New York, I call for more 'big data' to help secure a sustainable future (see also D. Griggs et al. Nature 495, 305-307; 2013) . We should be collecting big data that can be used to model and test an array of different scenarios for sustainably transforming the production and consumption of energy, improving food and water security, and eradicating poverty.
Managing these issues will Keep Australia's carbon pricing
Australia's new government may ditch the nation's pioneering carbon-pricing scheme in a move that would send a negative signal to other countries with plans for carbon trading or taxation (see E. Diringer Nature 501, 307-309; 2013) . Researchers and policy-makers need to be more effective in communicating such schemes to the public, to help guard against adversarial politics leading to inferior policy outcomes. In Australia's present carbonpricing system, emitters buy government permits for a fixed price of Aus$24 (US$22) per tonne of carbon dioxide produced. Under current law, this scheme is due to become a market-based emissionstrading scheme in 2015 and will allow trading with the cheaper emissions permits from the European Union.
The latest proposals retain Australia's target for lower emissions, but aim to replace the carbon-pricing scheme with government payments to companies that reduce emissions below a specified baseline. Critics include environmentalists, who fear that such a scheme would fail to meet Australia's emissions-reductions target, and economists, who say that it would compromise efficiency.
Although most experts regard a carbon price as the most efficient way of cutting emissions, it has been discredited in the popular discourse by opponents branding it as a punitive tax. In my view, inadequate communication with the public is partly to blame: Australia's former government failed to explain that carbon-pricing revenue is returned to low-and middle-income earners (under the new scheme, the taxpayer would pay to reduce emissions). Moreover, economists should have proclaimed their almost unanimous support for putting a price on carbon emissions. Learn from China's local pilot schemes I agree that international road maps for reducing carbon emissions will ultimately depend on stitching together inspired local initiatives (E. Diringer Nature 501, 307-309; 2013) . Good examples are the local pilot schemes set up nationwide in China (see, for example, Nature 498, 145-146; 2013) .
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The National Development and Reform Commission of China selected five provinces and eight cities in 2010 for the first round of low-carbon pilots, and has now included another province and 28 more cities in the second round. The scheme encourages policy innovation by local governments for low-carbon development and includes timetables for reducing greenhouse-gas emissions.
A survey by my team has revealed that several of these pilots are using innovative measures to upgrade conventional manufacturing and agriculture, to ensure that new industries, buildings and transportation conform with these plans, and to improve energy efficiency and carbon-sink capacity through ecological programmes. Xufeng Zhu Tsinghua University, Beijing, China. zhuxufeng@tsinghua.edu.cn After his diagnosis in May 2011, Halpin was surprised by the lack of treatments for people with his disease. This led him to ponder, from a statistical viewpoint, the regulatory systems that we apply to biomedical innovation, noting that they are much more riskaverse than the patients they are intended to serve. He believed that as a result, new medicines take longer to develop and are more costly than necessary.
His campaign has enabled drugs to get to market faster and more cheaply (see, for example, go.nature.com/gmgcyu). With support from academics, politicians and industrial scientists, he developed the Halpin Protocol (see go.nature. com/3z2wkd), which has sparked debate in the UK Parliament.
Halpin's campaign to overcome barriers to health-care translation will continue, aiming to lower them objectively and safely through increased flexibility in drug development and regulation. David A. Brindley University of Oxford, and CASMI, Oxford, UK; and Harvard Stem Cell Institute, Massachusetts, USA. david.brindley@ndorms.ox.ac 
